 Strategic Report
Highlights of 2017
rose 16% to EGP 540 million compared with EGP 466 million in 
2016, also constrained by post-devaluation inflationary pressures. 
reached EGP 51 million versus EGP 21 million a year earlier, 
reflecting highly effective management of excess cash.  
Operating profit Interest income 
to 383 in 2017 from 354 in 2016 represented 8% annual unit growth. of US$ 0.16 (sixteen US$ cents) per share, equivalent to US$ 24 
million in total, compared with US$ 0.14 (fourteen US$ cents) 
per share, equivalent to US$ 21 million in total in 2016.
Expansion of branch network Recommended final dividend 
increased 29% to EGP 1,514 million in 2017 from EGP 1, 171 
million in 2016, driven by a combination of better pricing, 
favourable currency translation and higher volumes.
gained 16% to EGP 730 million from EGP 628 million in 2016, 
despite ongoing inflationary pressures on raw material costs 
following the November 2016 floatation of the Egyptian pound.  
Revenues Gross profit  
grew 18% to EGP 602 million from EGP 511 million in 2016, 
despite higher raw material costs as well as higher rent and 
utilities expenses.
grew 44% year-on-year to EGP 384 million in 2017 versus EGP 
267 million in 2016, benefiting from increased interest income 
and a lower foreign exchange loss.
EBITDA
*
 Net profit   
of EGP 2.49 compared with EGP 1.74 in 2016. amounted to EGP 20 million, substantially lower than EGP 89 
million in 2016. 
Earnings per share Net foreign exchange loss
to 383 in 2017 from 354 in 2016 
represented 8% annual unit growth.
n et foreign  
exchange loss
Earnings  
per share
Recommended  
final dividend
Expansion  
of branch network
* EBITDA is calculated as operating profit (EGP 540 million) plus depreciation (EGP 62 million) and amortisation (nil).
IDH ANNUAl REPORT 2017 6 Egypt
Jordan
Sudan
Nigeria
our Brands
In Egypt, IDH’s largest market, the 
Group’s core brands include Al Borg 
and Al Mokhtabar, each of which is 
well-known and enjoys a loyal fol-
lowing. In Jordan, the Company op-
erates Biolab; in Sudan, Ultralab and 
Al Mokhtabar Sudan; and in Nigeria, 
Echo-Scan
*
. 
our Services
IDH offers more than 1,400 diagnos-
tic pathology tests, ranging from 
basic blood glucose tests for diabetes 
to advanced molecular testing for 
genetic disorders. 
our Geography
IDH’s geographic platform has expand-
ed to include four countries across the 
Middle East and Africa including Egypt, 
Sudan, Jordan and Nigeria
*
.
Immunology
Microbiology
Haematology
Endocrinology Clinical Chemistry Molecular Biology
Cytogenetics Histopathology
Radiology
*As at January 2018. 
IDH ANNUAl REPORT 2017  7
